News | December 24, 2023
Bristol Myers Squibb to buy Karuna Therapeutics for US$ 14 billion
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
His resignation would be effective from March 18, 2024
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
His most recent stint was with Danone India as its Managing Director
Lacosamide is indicated to treat partial-onset seizures
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
